Daily FNArena News - Small Caps

Despite a trial setback, Starpharma has some pundits seeing good value in multiple applications of its Dendrimer technology.

Robust demand for mining and communications technology signals strong outlook for Codan, according to Moelis.

RBS Morgans sees a favourable set-up for biotech Alchemia.

A solid full year profit result from Technology One and the expectation of further growth and potential capital management see both UBS and BA-ML retain Buy ratings on the stock.

Gold explorer Mount Magnet South has attracted DJ Carmichael’s attention as it prepares to become a producer next year.

Fantastic Furniture’s competitive and vertically integrated business should flourish with any housing and sentiment rebound, according to Goldman Sachs.

OctaPhillip is positive on the longer-term outlook for tin prices and to reflect this upgrades its rating on junior play Kasbah Resources to Buy.

Grange Resources had a tough September quarter and the uncertainty of any selldown of the Southdown project sees brokers remain cautious on the stock.

Amex resources is a small explorer on track for iron sands mine in Fiji. A robust feasibility study supports a 20-year mine life with low operating costs.

Fleetwood is feeling the effects of reduced occupancy in one of its villages and RBS has become more cautious on the near-term, but not longer term, outlook.